ArticleJournal of patient-reported outcomes2024

Improvements in quality of life of patients with multiple sclerosis receiving alemtuzumab in clinical practice: the LEMVIDA study.

José Eustasio Meca-Lallana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.